Lotus Ventures Inc. (the “Company” or “Lotus”) (CSE:J) (Frankfurt: LV9), an Okanagan based cannabis cultivator announces the resignation of Steve Mathieson as a Director and the appointment of Simon Davie. Steve is stepping down subsequent to Lotus reaching a long-awaited milestone; the receipt of a Standard Cultivation and Medical Sales cannabis license from Health Canada. Steve has been with Lotus from the beginning and has helped through our various stages of growth. We thank Steve for his contributions to the Company and we wish him all the best.

New Director Simon Davie:
Simon Davie is a certified Project Management Professional with specialized expertise in social purpose real estate development and has been a Managing Partner of Terra Housing Consultants Ltd. since 2003. The Terra group of companies is one of Canada’s most experienced development management firms having completed over 300 projects with current projects under development of approximately $600 million in asset value. Simon’s applicable experience to Lotus provides insights on project and regulatory matters, as well as assistance to the company when looking for a diversity of growing partners across Canada. Lotus will continue to build out the team and expand our production facilities now that it’s a licensed cannabis producer in Canada.

Lotus Ventures Inc.
“Dale McClanaghan”
Dale McClanaghan, President and CEO

About Lotus Ventures Inc.
Lotus Ventures is a licensed cannabis producer under the Cannabis Act and Cannabis Regulations, holding a Standard Cultivation and Sale for Medical Purposes license. The Company’s business model combines an upstream royalty financing model with Auxly Cannabis Group Inc. and a downstream licensing model with partners utilizing Lotus intellectual property. The initial 22,500 square foot facility in Spallumcheen, B.C. is a purpose built, state of the art indoor facility with proprietary processes.

SOURCE Lotus Ventures Inc.

For further information: Dale McClanaghan, CEO: dalemcclanaghan@gmail.com, (604) 644-9844; Daniel McRobert, Investor Relations: danielmcrobertt@gmail.com, (604) 842-4625

Click here to connect with Lotus Ventures Inc (CSE:J) for an Investor Presentation.

Source: www.newswire.ca

Strong Innovation Pipeline Continues to Drive Market Share Growth
Broken Coast’s First Foray into Cannabis 2.0
Solei Introduces First Limited Release Vape on the Market
Solei, RIFF, Good Supply and B!NGO Expand Product Offerings

Aphria Inc. (” Aphria ” or the ” Company “) ( TSX: APHA and NASDAQ: APHA ), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, today announced the expansion of its 510 Vape offering across its award-winning adult-use brand portfolio.

Keep reading... Show less

Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”). If you wish to serve as lead plaintiff, you must move the Court before the December 1 2020 DEADLINE . A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=aurora-cannabis-inc&id=2437 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email info@zhanginvestorlaw.com for information on the class action.

Keep reading... Show less

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (“Nextleaf Solutions“, “OILS”, or the “Company”), Canada’s most innovative cannabis extractor, is pleased to provide the following commercial and intellectual property update:

Cannabis Extraction Agreement with White Label Producer

Keep reading... Show less


Khiron Life Sciences Corp. (“ Khiron ” or, the “ Company ”) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to announce that it has closed today its previously announced “bought deal” short form prospectus offering of units (“ Unit s ”), including the exercise in full of the over-allotment option (the “ Offering ”).

Keep reading... Show less

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, is scheduled to speak on a panel at the Cowen 2020 Boston Cannabis Conference on Wednesday, December 2, 2020 at 9:20 a.m. EST.

For more information regarding the Cowen 2020 Boston Cannabis Conference please visit: https://www.cowen.com/conferences-and-events/3rd-annual-boston-cannabis-conference/

Keep reading... Show less